PHAT - Phathom Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PHAT is currently covered by 5 analysts with an average price target of $24. This is a potential upside of $12.63 (117.19%) from yesterday's end of day stock price of $11.05.

Phathom Pharmaceuticals's activity chart (see below) currently has 74 price targets and 91 ratings on display. The stock rating distribution of PHAT is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 24.17% with an average time for these price targets to be met of 84.45 days.

Highest price target for PHAT is $29, Lowest price target is $18, average price target is $24.

Most recent stock forecast was given by from HC WAINWRIGHT on 17-Jun-2026.

Best performing analysts who are covering PHAT - Phathom Pharmaceuticals:

Paul Choi Glen Santangelo Kristen Kluska Chase Knickerbocker

Currently out of the existing stock ratings of PHAT, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Aug-2023

$26

$15.28 (142.54%)

$26

29 days ago
(17-Jun-2026)

0/9 (0%)

$15 (136.36%)

Hold Since 27-Mar-2026

$18

$7.28 (67.91%)

$13

3 months 19 days ago
(27-Mar-2026)

2/3 (66.67%)

$7.42 (70.13%)

444

Buy Since 02-Feb-2021

$25

$14.28 (133.21%)

$20

4 months 19 days ago
(27-Feb-2026)

1/6 (16.67%)

$12.44 (99.04%)

134

Buy Since 07-Mar-2025

$22

$11.28 (105.22%)

$17

8 months 15 days ago
(31-Oct-2025)

1/3 (33.33%)

$8.45 (62.36%)

193

Buy Since 06-Jun-2025

$29

$18.28 (170.52%)

$29

9 months 1 days ago
(15-Oct-2025)

0/3 (0%)

$15.55 (115.61%)

Show more analysts

Please expand the browser size to see the chart

What is PHAT (Phathom Pharmaceuticals) average time for price targets to be met?

On average it took 84.45 days on average for the stock forecasts to be realized with a an average price target met ratio 24.17

Which analyst has the current highest performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?

PAUL CHOI

Which analyst has the most public recommendations on PHAT (Phathom Pharmaceuticals)?

Paul Choi has 6 price targets and 5 ratings on PHAT

Which analyst is the currently most bullish on PHAT (Phathom Pharmaceuticals)?

Prakhar Agrawal with highest potential upside - $49.37

Which analyst is the currently most reserved on PHAT (Phathom Pharmaceuticals)?

Paul Choi with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?